ArticleCureus2026
Congenital Thrombotic Thrombocytopenic Purpura Presenting as Recurrent Ischemic Stroke in a Young Adult: A Genetically Confirmed Case.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Thrombotic thrombocytopenic purpura (TTP) is a rare thrombotic microangiopathy that can present with neurological and renal involvement and may rarely manifest as acute ischemic stroke in young adults. We report the case of a 23-year-old male who presented with acute-onset right-sided hemiplegia and expressive aphasia, with a history of recurrent transient ischemic attacks and renal dysfunction. Laboratory evaluation revealed severe thrombocytopenia, microangiopathic hemolytic anemia with schistocytes, and markedly elevated renal parameters. Neuroimaging demonstrated an acute infarct predominantly involving the left parietal region with additional subacute infarcts, while intracranial vessels were normal. A PLASMIC (Platelet count, combined Hemolysis parameters, Absence of active cancer, no history of solid Organ or Stem cell transplant, MCV (mean corpuscular volume), INR (international normalized ratio), and Creatinine) score of 5 indicated an intermediate risk for severe ADAMTS13 deficiency. The patient was treated with high-dose corticosteroids during the acute phase along with supportive therapy. Genetic testing subsequently confirmed congenital TTP due to a homozygous ADAMTS13 mutation. This case highlights TTP as an important, though uncommon, cause of young stroke and underscores the need for early recognition to enable timely management and prevent recurrent thrombotic events.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.